NEW YORK (TheStreet) -- Roche Holding Ltd. (RHHBY) will pay up to $1.725 billion to buy Seragon Pharmaceuticals, a privately-held, San Diego-based biotech company that researches breast cancer treatments, Reuters reports.
The company was spun out from Aragon Pharmaceuticals in 2013 when that company was bought by Johnson & Johnson (JNJ), Reuters noted.
Roche Holding shares closed slightly lower at $37.29 yesterday.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts